In HCC, AIMP3, one of the macromolecular protein complex cofactors of ARSs, is reduced in HCC [19], and overexpression of glycyl-tRNA synthetase (GARS) was considered for a biomarker of poor prognosis in patients [20]. This evidence concerns the gene GARS1 and hepatocellular carcinoma.